Sensex Today | Stock Market LIVE Updates: GIFT Nifty trades with discount of 10 points, sheds losses

SUN PHARMA

SUN PHARMA in Focus

Other stocks – DRL, Lupin, Torrent, Glenmark

Generic pharma stocks not impacted by news

Pharma stocks are likely to be under pressure due to the fear of further steps on pharma by the Trump Administration

CLSA on Asian Paints

Seshaasai Technologies will finalise the allotment of its ₹813.07-crore IPO on Friday, September 26.

The IPO, which opened on September 23 and closed on September 25, included a fresh issue of 1.13 crore shares worth ₹480 crore and an offer-for-sale of 79 lakh shares totalling ₹333.07 crore.

Read Full Article

Indian pharmaceutical firms, including Sun Pharma, Aurobindo Pharma, Gland Pharma, Lupin, and Cipla, will be under the spotlight on Friday, September 26, following US President Donald Trump’s announcement of 100% tariffs on branded and patented drugs, effective from October 1.

Read Full Article

CITI on IT

Anand Rathi Share & Stock Brokers is set to finalise the allotment of its ₹745 crore IPO on Thursday, September 26.

The book-built issue includes a fresh offer of 1.80 crore shares, with bidding open from September 23 to September 25.

Read Full Article

Nomura on Titan

Nomura on HAL

Morgan Stanley on HAL

Ather Energy

The US economy expanded more quickly than initially estimated in Q2, with revised figures highlighting its resilience despite challenges from trade policies and slowing global growth.

Read Full Article

Supreme Petrochem has commissioned an Acrylonitrile Butadiene Styrene (ABS) project with a capacity of 70,000 tonne per annum (TPA) at its Maharashtra plant.

Read Full Article

Mahindra and Mahindra (M&M) is set to release its results for the July to September quarter of 2025 (Q2FY26) on November 4.

TRADE SET UP

Cash flows on Sep 25, 2025

FII Net Sell ₹4,995 Cr

DII Net Buy ₹5,103 Cr

FIIs IN INDEX FUTURES

Contracts Change in OI Positioning

Longs +3,894 16%

Shorts +6481 84%

FII Writing Index Options (contracts)

Calls +102342

Puts +69860

OPTION CUES

Nifty PCR at 0.68 Vs 0.87

NIFTY OPTIONS (Sep 30)

Strike Change in OI Premium

25000 call +115.2 lk shares 80

24900 put +25.8 lk shares 67

Nifty levels

Support 24800

Resistance 25100

Nifty Bank with 20 DMA

Margin Trading Funding

23-Sep-2025 98220cr

Source: NSE

F&O BAN:

OUT OF BAN: HFCL

Ceigall India has been awarded a Letter of Award (LoA) by Greater Mohali Area Development Authority (GMADA) for a road construction project valued at ₹509 crore.

Accenture reported fourth-quarter revenue of $17.6 billion on Thursday, topping Wall Street expectations. Robust demand for AI-driven consulting and digital services boosted results, sending its shares up 3.7% in premarket trading.

Read Full Article

Jobless claims in the US fell unexpectedly last week, easing worries about softness in the labour market.

Read Full Article

Strong US economic statistics and conflicting signals from Fed officials regarding rate cuts caused concerns about exaggerated Wall Street values, which caused Asian equities to decline at the opening.

After the S&P 500 fell for the third consecutive session—the longest decline in a month—shares in South Korea, Japan, and Australia opened lower.

On Thursday, September 25, the Nifty fell for the fifth session in a row, weighed down by weak global cues. The index dropped 166 points to close at 24,890, erasing more than half of the gains from its rally between August 29 (24,404) and September 18 (25,448).

Read Full Article

On Friday, September 26, Seshaasai Technologies Limited is expected to complete the distribution of shares for its ₹813.07-crore IPO. The initial public offering (IPO) ended today, September 25, after opening for subscriptions on September 23. It included an offer-for-sale component of 79 lakh shares for ₹333.07 crore and a new issue of 1.13 crore shares worth ₹480 crore.

GIFT Nifty is trading over 90 points below Wednesday’s Nifty Futures close, signalling a gap-down opening for Indian markets.

As US President Donald Trump stepped up pressure on Russian energy purchasers in an effort to stop the war in Ukraine, oil was poised for its largest weekly rise in over three months.

Brent closed above $69 on Thursday, while West Texas Intermediate saw no movement and settled above $65 per barrel.

Donald Trump Says | Trump Tariffs

Will Be Imposing a 50% Tariff On Kitchen Cabinets, Bathroom Vanities, & Associated Products, with effect from October 1

Will Be Charging 30% Tariff On Upholstered Furniture Due To ‘Flooding’ Of Products Into US By Other Countries

It Is An Unfair Practice, But We Must Protect, For National Security & Other Reasons, Our Manufacturing Process

Will Impose 100% Tariff On Branded, Patented Drugs Unless Firms Build Plants Locally

Trump Tariffs | Donald Trump Plans To Impose 25% Tariff On Truck Imports From October 1

Donald Trump | Approves TikTok Deal Through Exec Order, VP Says Business Valued At $14 Billion

In 2025, the difference in performance between India’s two main indices — the Nifty50 and the Sensex — has reached its widest level in four years.

So far this year, the Nifty50 has risen 5.3%, while the Sensex is up just 3.9%, lagging by 1.4 percentage points.

Read Full Article

Waaree Energies under US probe for evading solar tariff duties, Bloomberg News reports

A 100% charge on branded or patented drugs will go into effect on October 1st, unless a corporation is constructing a manufacturing facility in the United States, according to a new round of tariffs announced by President Donald Trump.

Trump stated on social media that if businesses have started building a US manufacturing facility or if one is already under development, there won’t be any taxes on pharmaceutical imports.

Welcome to CNBC-TV18’s Market Blog

Good morning, readers! Welcome to CNBC-TV18’s market blog, where we provide rolling live news coverage of the markets, lineup of TV guests, in-house editors, researchers and reporters.